{"id":"https://openalex.org/W4200289901","doi":"https://doi.org/10.3389/fphar.2021.750672","title":"Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplantation","display_name":"Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplantation","publication_year":2021,"publication_date":"2021-12-07","ids":{"openalex":"https://openalex.org/W4200289901","doi":"https://doi.org/10.3389/fphar.2021.750672","pmid":"https://pubmed.ncbi.nlm.nih.gov/34950026","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8689075"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2021.750672","doi":"https://doi.org/10.3389/fphar.2021.750672","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.750672","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.750672/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.750672/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089574390","display_name":"Jordan T. Brooks","orcid":"https://orcid.org/0000-0001-9060-9714","observed_orcids":["https://orcid.org/0000-0001-9060-9714"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jordan T. Brooks","raw_affiliation_strings":["Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, San Francisco, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, San Francisco, CA, United States","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061094080","display_name":"Ron J. Keizer","orcid":"https://orcid.org/0000-0002-2460-7056","observed_orcids":["https://orcid.org/0000-0002-2460-7056"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ron J. Keizer","raw_affiliation_strings":["Insight RX, Inc, San Francisco, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Insight RX, Inc, San Francisco, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062929622","display_name":"Janel Renee Long-Boyle","orcid":"https://orcid.org/0009-0002-5545-2808","observed_orcids":["https://orcid.org/0009-0002-5545-2808"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janel R. Long-Boyle","raw_affiliation_strings":["Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, San Francisco, CA, United States","Department of Pediatrics, University of California, San Francisco, San Francisco, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, San Francisco, CA, United States","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Department of Pediatrics, University of California, San Francisco, San Francisco, CA, United States","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059940608","display_name":"Sandhya Kharbanda","orcid":"https://orcid.org/0000-0002-6014-7659","observed_orcids":["https://orcid.org/0000-0002-6014-7659"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandhya Kharbanda","raw_affiliation_strings":["Department of Pediatrics, University of California, San Francisco, San Francisco, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, University of California, San Francisco, San Francisco, CA, United States","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047178145","display_name":"Christopher C. Dvorak","orcid":"https://orcid.org/0000-0002-6146-3952","observed_orcids":["https://orcid.org/0000-0002-6146-3952"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher C. Dvorak","raw_affiliation_strings":["Department of Pediatrics, University of California, San Francisco, San Francisco, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, University of California, San Francisco, San Francisco, CA, United States","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068686662","display_name":"Brian D. Friend","orcid":"https://orcid.org/0000-0001-8652-4400","observed_orcids":["https://orcid.org/0000-0001-8652-4400"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Brian D. Friend","raw_affiliation_strings":["Department of Pediatrics, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, United States","institution_ids":["https://openalex.org/I181547552"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5068686662"],"corresponding_institution_ids":["https://openalex.org/I181547552"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.4277,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.81133448,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"12","issue":null,"first_page":"750672","last_page":"750672"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":1.0},{"id":"https://openalex.org/keywords/population-pharmacokinetic-model","display_name":"population pharmacokinetic model","score":0.9330000281333923},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.9290000200271606},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.9440000057220459},{"id":"https://openalex.org/keywords/young-adults","display_name":"young adults","score":0.8619999885559082},{"id":"https://openalex.org/keywords/continuous-intravenous-infusion","display_name":"continuous intravenous infusion","score":0.7620000243186951},{"id":"https://openalex.org/keywords/bayesian-forecasting","display_name":"Bayesian forecasting","score":0.6019999980926514},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.8410000205039978},{"id":"https://openalex.org/keywords/allometric-scaling","display_name":"allometric scaling","score":0.8669999837875366},{"id":"https://openalex.org/keywords/covariate-analysis","display_name":"covariate analysis","score":0.515999972820282},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.6909999847412109},{"id":"https://openalex.org/keywords/tacrolimus-trough-levels","display_name":"tacrolimus trough levels","score":0.5460000038146973},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8177540302276611},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6983720064163208},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.6641709208488464},{"id":"https://openalex.org/C2776239304","wikidata":"https://www.wikidata.org/wiki/Q6954915","display_name":"NONMEM","level":3,"score":0.6583559513092041},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5866978764533997},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5220118165016174},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.4995851516723633},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.476860374212265},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.45419836044311523},{"id":"https://openalex.org/C31785415","wikidata":"https://www.wikidata.org/wiki/Q7846541","display_name":"Trough level","level":4,"score":0.4509451389312744},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3242592215538025},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fphar.2021.750672","doi":"https://doi.org/10.3389/fphar.2021.750672","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.750672","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.750672/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8689075","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8689075","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:34950026","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34950026","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:4cec0f044ca04910b9a50ec39f3f3173","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4cec0f044ca04910b9a50ec39f3f3173","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 12 (2021)","raw_type":"article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt2s39n0t5","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/2s39n0t5","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, vol 12","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2021.750672","doi":"https://doi.org/10.3389/fphar.2021.750672","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2021.750672","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2021.750672/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332622","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200289901.pdf","grobid_xml":"https://content.openalex.org/works/W4200289901.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1539005347","https://openalex.org/W1636259116","https://openalex.org/W1913100467","https://openalex.org/W2000949817","https://openalex.org/W2033139608","https://openalex.org/W2064422560","https://openalex.org/W2074839667","https://openalex.org/W2091718723","https://openalex.org/W2111599151","https://openalex.org/W2122527560","https://openalex.org/W2147937089","https://openalex.org/W2725436133","https://openalex.org/W2925694497","https://openalex.org/W2981619631","https://openalex.org/W3003959691","https://openalex.org/W3039427579","https://openalex.org/W3086250822","https://openalex.org/W3155898736"],"related_works":["https://openalex.org/W4286631747","https://openalex.org/W4380880464","https://openalex.org/W1997062945","https://openalex.org/W2925694497","https://openalex.org/W2091718723","https://openalex.org/W2058653310","https://openalex.org/W2555303823","https://openalex.org/W7096513448","https://openalex.org/W15245744","https://openalex.org/W4386760310"],"abstract_inverted_index":{"Background:":[0],"With":[1],"a":[2,87,114,221,258,317],"notably":[3],"narrow":[4],"therapeutic":[5,21,270],"window":[6],"and":[7,10,35,64,71,100,108,130,172,181,229,246,262,279,289],"wide":[8],"intra-":[9],"interindividual":[11],"pharmacokinetic":[12],"(PK)":[13],"variability,":[14],"initial":[15],"weight-based":[16],"dosing":[17,260,311],"along":[18],"with":[19,240],"routine":[20],"drug":[22,271],"monitoring":[23,272],"of":[24,68,75,80,127,196,226,231,305,312],"tacrolimus":[25,37,45,93,137,198,275,306,315],"are":[26,284],"employed":[27],"to":[28,51,85,151,286],"optimize":[29],"its":[30],"clinical":[31,293,299],"utilization.":[32],"Both":[33],"supratherapeutic":[34],"subtherapeutic":[36],"concentrations":[38,202,245],"can":[39],"result":[40],"in":[41,53,60,97,113,142,162,205,257,292,301],"poor":[42],"outcomes,":[43],"thus":[44],"PK":[46,89],"variability":[47],"is":[48],"particularly":[49],"important":[50],"consider":[52],"the":[54,58,81,98,110,143,179,206,216,266,277,303],"pediatric":[55,99,129,278],"population":[56,88,107,283],"given":[57],"differences":[59],"absorption,":[61],"distribution,":[62],"metabolism,":[63],"excretion":[65],"among":[66],"children":[67],"various":[69],"sizes":[70],"at":[72,154,243,249,265],"different":[73],"stages":[74],"development.":[76],"The":[77,164,253,295],"primary":[78],"goals":[79],"current":[82],"study":[83],"were":[84,203],"develop":[86],"(PopPK)":[90],"model":[91,112,158,166,191,213,234,254,296],"for":[92,274],"IV":[94,136],"continuous":[95,139,314],"infusion":[96,140],"young":[101,131,280],"adult":[102,132,281],"hematopoietic":[103],"cell":[104],"transplant":[105],"(HCT)":[106],"implement":[109],"PopPK":[111,157,165,207],"clinically":[115],"available":[116,264],"Bayesian":[117,259,318],"forecasting":[118,319],"tool.":[119],"Methods:":[120],"A":[121,194,210],"retrospective":[122],"chart":[123],"review":[124],"was":[125,160,220,255],"conducted":[126],"111":[128],"patients":[133],"who":[134],"received":[135],"by":[138,307],"early":[141],"post-transplant":[144],"period":[145],"during":[146],"HCT":[147,282],"from":[148],"February":[149],"2016":[150],"July":[152],"2020":[153],"our":[155],"institution.":[156],"building":[159,167],"performed":[161],"NONMEM.":[163],"process":[168],"included":[169,204],"identifying":[170,183],"structural":[171,212],"random":[173],"effects":[174],"models":[175],"that":[176,223],"best":[177,214],"fit":[178,215],"data":[180],"then":[182],"which":[184],"patient-specific":[185],"covariates":[186],"(if":[187],"any)":[188],"further":[189],"improved":[190,224],"fit.":[192],"Results:":[193],"total":[195],"1,648":[197],"plasma":[199],"steady-state":[200],"trough":[201],"modeling":[208],"process.":[209],"2-compartment":[211],"data.":[217],"Allometrically-scaled":[218],"weight":[219],"covariate":[222],"estimation":[225],"both":[227],"clearance":[228],"volume":[230],"distribution.":[232],"Overall,":[233],"predictions":[235],"only":[236],"showed":[237],"moderate":[238],"bias,":[239],"minor":[241,247],"under-prediction":[242],"lower":[244],"over-prediction":[248],"higher":[250],"predicted":[251],"concentrations.":[252],"implemented":[256],"tool":[261],"made":[263],"point-of-care.":[267],"Discussion:":[268],"Novel":[269],"strategies":[273],"within":[276],"necessary":[285],"reduce":[287],"toxicity":[288],"improve":[290],"efficacy":[291],"practice.":[294],"developed":[297],"presents":[298],"utility":[300],"optimizing":[302],"use":[304],"enabling":[308],"model-guided,":[309],"individualized":[310],"IV,":[313],"via":[316],"platform.":[320]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2021-12-31T00:00:00"}